One supplement (SNDS #276224, filed June 16, 2023) resulted in a Notice of Compliance issued November 1, 2023, with modifications to the Warnings and Precautions and Adverse Reactions sections of the product monograph [Source: dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00629]
A larger phase IIb trial of intranasal glutathione (300 mg/dose, three times daily for 3 months, n=45) also showed no significant improvement over placebo (Mischley et al., J Parkinsons Dis, 2017) [52]
Patients should aim for sufficient water intake throughout the day
This n-of-1 approachtreating your own body as the experimentyields faster optimization than population-average recommendations
Variations in the GLP1R gene, GIPR gene, and serotonin-pathway genes influence both therapeutic response and the likelihood of experiencing anxiety during treatment